Sword Bio Appoints Seth Reid as Vice President, Business Development


Sword Bio (“Sword”), a contract research organization that supports biotech and pharmaceutical companies with their bioanalytical needs for pre-clinical and clinical trials, announces the appointment of Seth Reid as VP, Business Development. 

Seth joins Sword with a proven track record leading and supporting business development programs in the contract research space. Most notably, Sr. Director/Head, of Large Molecule Business Development & Strategic Accounts for BioAgilytix.  In this position Seth led a North America dispersed team of business development professionals, working within territories promoting commercial growth, enhancing client satisfaction, and nurturing opportunities for client specific initiatives.

“I’m excited to have Seth join us as we grow our world-class team,” said David Dingott, CEO. “Seth builds a keen understanding of the needs of each of our clients and has a long and successful history of supporting his customers from precontract technical meetings through project completion”

“I am truly excited to join the Sword team and have the opportunity to provide quality bioanalytical services to our clients“ said Seth.  “I value the collaborative partnership approach, open communication, and flexibility Sword can offer to clients to meet their critical project needs and timelines.  It is a very competitive marketplace and Sword can enable clients to be empowered by aligning strategic goals and outsourcing projects to our talented team”.  

About Sword

Sword Bio is a bioanalytical CRO satisfying the needs of biotech and pharmaceutical companies. The sword team is built with experts in assay development, validation and sample analysis under Non-GLP or GLP. We support our clients with PK, biomarker, and immunogenicity assays for research, pre-clinical and clinical studies.

Sword’s team of highly experienced science and QA professionals ensures high-quality science, data integrity and regulatory compliance through all phases of clinical development. We pride ourselves on starting projects quickly so that our clients can quickly achieve their goals.  

For more information, visit www.swordbio.com.